GLASSIA is a Intravenous Injection, Solution in the Plasma Derivative category. It is labeled and distributed by Baxalta Us Inc.. The primary component is .alpha.1-proteinase Inhibitor Human.
| Product ID | 0944-2884_08d8f23f-5ecb-431c-bb45-0183756d7a8b |
| NDC | 0944-2884 |
| Product Type | Plasma Derivative |
| Proprietary Name | GLASSIA |
| Generic Name | .alpha.1-proteinase Inhibitor Human |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2010-07-01 |
| Marketing Category | BLA / BLA |
| Application Number | BLA125325 |
| Labeler Name | Baxalta US Inc. |
| Substance Name | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
| Active Ingredient Strength | 1 g/50mL |
| Pharm Classes | Human alpha-1 Proteinase Inhibitor [EPC], Trypsin Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2010-07-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA125325 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2014-04-04 |
| Marketing Category | BLA |
| Application Number | BLA125325 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2010-07-01 |
| Ingredient | Strength |
|---|---|
| .ALPHA.1-PROTEINASE INHIBITOR HUMAN | 1 g/50mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0944-2884 | GLASSIA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
| 0053-7202 | ZEMAIRA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
| 0053-7203 | ZEMAIRA | .ALPHA.1-PROTEINASE INHIBITOR HUMAN |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() GLASSIA 88833225 not registered Live/Pending |
Crilamex, S.A. de C.V. 2020-03-13 |
![]() GLASSIA 77925761 3871558 Live/Registered |
KAMADA LTD. 2010-02-02 |